Product Information
Mounjaro 2.5 mg solution for injection is a groundbreaking treatment developed for adults with Type 2 diabetes, and it has shown exceptional promise in promoting healthy, sustainable weight loss—even in individuals without diabetes. Its active ingredient, Tirzepatide, acts on two important hormones (GLP-1 and GIP) that regulate insulin levels and appetite, making it uniquely effective for reducing body weight while improving blood sugar control.
This 2.5 mg dose is typically the starting point in a titration plan, with dosage gradually increased by your doctor based on your body’s response. Administered once weekly using a pre-filled injection pen, Mounjaro helps control hunger, slows gastric emptying, and improves metabolic efficiency—making it a powerful option for individuals struggling with obesity or insulin resistance.
Key Benefits:
- Clinically proven to reduce up to 15%–20% of body weight in long-term studies
- Suppresses appetite and reduces cravings
- Enhances the body’s ability to burn fat
- Improves insulin response and prevents fat storage
- Complements healthy diet and exercise routines
How to Use:
Start with 2.5 mg weekly, increasing gradually under medical supervision
Administer subcutaneously in the abdomen, thigh, or upper arm
Use the same day each week, with or without food
Rotate injection sites weekly
Storage Instructions:
- Store in refrigerator (2°C to 8°C)
- May be stored at room temperature (up to 30°C) for 21 days
- Do not freeze or reuse the pen
- Once removed from refrigeration, do not return it to the fridge
